Article Details

Elucida Oncology Announces First Patient Dosed in Phase 1/2 Study of ELU001 in ... - wdrb.com

Retrieved on: 2021-09-17 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

Elucida Oncology Announces First Patient Dosed in Phase 1/2 Study of ELU001 in ... - wdrb.com. View article details on hiswai:

Excerpt

17, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that it has ...

Article found on: www.wdrb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up